March 28, 2017 10:40 AM ET

Biotechnology

Company Overview of XyloCor Therapeutics, Inc.

Key Executives for XyloCor Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Albert Gianchetti 2 RelationshipsPresident, Chief Executive Officer, and Director--

XyloCor Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Albert Gianchetti 2 RelationshipsXyloCor Therapeutics, Inc.--
Glenn V. Batchelder 16 RelationshipsCivitas Therapeutics, Inc.54
James Cohen 2 RelationshipsXyloCor Therapeutics, Inc.--
View All Board Members

XyloCor Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
322.0K
Bonus
253.3K
Total Short Term Compensation
411.5K
Total Value of Options
2.7M
Compensation as of Fiscal Year
XyloCor Therapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Threshold Pharmaceuticals, Inc. and Molecular Templates, Inc. Announce Executive Appointments to Combined Company
March 27, 2017 9:01 PM ET
Threshold Pharmaceuticals, Inc. and Molecular Templates, Inc. Announce Executive Appointments to Combined Company
March 27, 2017 9:01 PM ET
Coherus BioSciences, Inc. Appoints Erik Wiberg as Executive Vice President of Corporate Development
March 27, 2017 9:00 PM ET
Aquinox Pharmaceuticals, Inc. Announces Board Appointments
March 27, 2017 8:02 PM ET
Aptose Biosciences Inc. Announces Resignation of Avanish Vellanki as Senior Vice President and Chief Business Officer
March 27, 2017 1:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact XyloCor Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.